Form 4: Journey Medical Corp President & CEO Sells Shares to Cover Tax Obligations

Claude Maraoui, President & CEO of Journey Medical Corp, sold 49,271 shares of common stock to cover tax withholding obligations related to vesting restricted stock units.

Summary

• On March 11, 2025, Claude Maraoui, the President & CEO of Journey Medical Corp, sold 49,271 shares of the company's common stock at a price of $5.01 per share.
• The sale was executed to satisfy tax withholding obligations associated with the vesting of restricted stock units.
• The reporting person had no discretion over the sale, which was conducted automatically according to the company's policies.
• Following the transaction, Maraoui still beneficially owns 2,003,147 shares, including restricted stock units that vest over time.

Sentiment

Score: 5

Explanation: The document is a standard SEC Form 4 filing, indicating a routine transaction. It doesn't inherently convey positive or negative sentiment.

Industry Context

Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives.

Stakeholder Impact

• The sale of shares by a key executive could have a minor impact on shareholder sentiment, but the reason for the sale (tax obligations) is a common and generally understood practice.

Key Dates